{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T02:12:38Z","timestamp":1776132758563,"version":"3.50.1"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T00:00:00Z","timestamp":1650240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Aim<\/jats:title><jats:p>We performed a comparative study to investigate the efficacy of closed system transfer devices (CSTDs) on the safe handling of injectable hazardous drugs (HDs).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The exposure assessments of cyclophosphamide and cytarabine were performed under traditional or CSTDs. For preparation activity, chemotherapy contamination samples on protective equipment (such as gloves and masks) were collected. The contamination analysis was performed by liquid chromatography with tandem mass spectrometry (LC-MS\/MS). A 6-item form was distributed monthly (form M1\u2013M6, total 6 months) to assess the pharmacists' experience on ergonomics, encumbrance, and safety impression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Totally, 96 wiping samples were collected throughout the study. The numbers of contaminated cyclophosphamide samples reduced under CSTD were \u221237.8, \u221241.6, \u221267.7, \u221247.3, and \u221222.9% and cytarabine were \u221212.3, \u221212.1, \u221220.6, \u221269.6, and \u221256.7% for left countertop, right countertop, medial glass, air-intake vent and door handle, as compared to traditional devices. The reduction was similar to pharmacist devices, i.e., \u221248.2 and \u221250.0% for masks and gloves cyclophosphamide contamination, \u221218.0 and \u221242.4% for cytarabine. This novel system could improve contamination on dispensing table, transfer container, and dispensing basket by \u221216.6, \u22126.0, and \u221222.3% for cyclophosphamide and \u221228.5, \u221222.5, and \u221246.2% for cytarabine. A high level of satisfaction was consistently associated with ergonomics for CSTD during the compounding process. Meanwhile, a slightly decreased satisfaction on ergonomics, encumbrance, and safety impression was observed for the traditional system between M2 and M3.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Closed system transfer devices are offering progressively more effective alternatives to traditional ones and consequently decrease chemotherapy exposure risk on isolator surfaces.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2022.827835","type":"journal-article","created":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T05:06:13Z","timestamp":1650258373000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Evaluation of Closed System Transfer Devices in Preventing Chemotherapy Agents Contamination During Compounding Process\u2014A Single and Comparative Study in China"],"prefix":"10.3389","volume":"10","author":[{"given":"YiWen","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XiaoTian","family":"Che","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan Li","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1539\/joh.50.48","article-title":"Evaluation of occupational exposure to antiblastic drugs in an Italian hospital oncological department","volume":"50","author":"Castiglia","year":"2008","journal-title":"J Occup Health."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1097\/JOM.0b013e3181f72b63","article-title":"Evaluation of antineoplastic drug exposure of health care workers at three university-based US cancer centers","volume":"52","author":"Connor","year":"2010","journal-title":"J Occup Environ Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/annhyg\/meu019","article-title":"Antineoplastic drug contamination on the hands of employees working throughout the hospital medication system","volume":"58","author":"Hon","year":"2014","journal-title":"Ann Occup Hyg."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.2146\/ajhp180564","article-title":"ASHP guidelines on handling hazardous drugs","volume":"75","author":"Power","year":"2018","journal-title":"Am J Health Syst Pharm."},{"key":"B5","first-page":"1","article-title":"NIOSH Alert: preventing occupational exposures to antineoplastic and other hazardous drugs in health care settings","volume":"2004","author":"Connor","year":"2004","journal-title":"Atlanta DHHS."},{"key":"B6","volume-title":"USP <797>: Guidebook to Pharmaceutical Compounding: Sterile Preparations","year":"2008"},{"key":"B7","doi-asserted-by":"publisher","first-page":"273","DOI":"10.5491\/SHAW.2011.2.3.273","article-title":"Occupational exposure to antineoplastic drugs: identification of job categories potentially exposed throughout the hospital medication system","volume":"2","author":"Hon","year":"2011","journal-title":"Saf Health Work."},{"key":"B8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2146\/ajhp160948","article-title":"Multicenter evaluation of a new closed system drug-transfer device in reducing surface contamination by antineoplastic hazardous drugs","volume":"75","author":"Bartel","year":"2018","journal-title":"Am J Health Syst Pharm."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1093\/ajhp\/60.22.2314","article-title":"Using a closed-system protective device to reduce personnel exposure to antineoplastic agents","volume":"60","author":"Wick","year":"2003","journal-title":"Am J Health Syst Pharm."},{"key":"B10","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1310\/hpj4803-204","article-title":"Reduction in surface contamination with cyclophosphamide in 30 US hospital pharmacies following implementation of a closed-system drug transfer device","volume":"48","author":"Sessink","year":"2013","journal-title":"Hosp Pharm."},{"key":"B11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1177\/1078155214544993","article-title":"Evaluation of a closed-system cytotoxic transfer device in a pharmaceutical isolator","volume":"22","author":"Vyas","year":"2016","journal-title":"J Oncol Pharm Pract."},{"key":"B12","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1177\/1078155210381931","article-title":"Occupational exposure to antineoplastic drugs in seven Italian hospitals: the effect of quality assurance and adherence to guidelines","volume":"17","author":"Turci","year":"2011","journal-title":"J Oncol Pharm Pract."},{"key":"B13","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1093\/ajhp\/62.5.475","article-title":"Surface contamination of chemotherapy drug vials and evaluation of new vial-cleaning techniques: results of three studies","volume":"62","author":"Connor","year":"2005","journal-title":"Am J Health Syst Pharm."},{"key":"B14","doi-asserted-by":"publisher","first-page":"428","DOI":"10.2146\/ajhp080621","article-title":"Surface contamination of antineoplastic drug vials: comparison of unprotected and protected vials","volume":"67","author":"Schierl","year":"2010","journal-title":"Am J Health Syst Pharm."},{"key":"B15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/1078155210374673","article-title":"Evaluation of surface contamination with cyclophosphamide following simulated hazardous drug preparation activities using two closed-system products","volume":"17","author":"Zock","year":"2011","journal-title":"J Oncol Pharm Pract."},{"key":"B16","first-page":"351","article-title":"Pilot study comparing the efficacy of two cleaning techniques in reducing environmental contamination with cyclophosphamide","volume":"54","author":"Touzin","year":"2010","journal-title":"Ann Occup Hyg."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e0159052","DOI":"10.1371\/journal.pone.0159052","article-title":"Effectiveness of a closed-system transfer device in reducing surface contamination in a new antineoplastic drug-compounding unit: a prospective, controlled, parallel study","volume":"11","author":"Simon","year":"2016","journal-title":"PLoS One."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1177\/1078155218787256","article-title":"Application of the 2015 proposed NIOSH vapor containment performance protocol for closed system transfer devices used during pharmacy compounding and administration of hazardous drugs","volume":"25","author":"Forshay","year":"2019","journal-title":"J Oncol Pharm Pract."},{"key":"B19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/annhyg\/men081","article-title":"Use of a closed system device to reduce occupational contamination and exposure to antineoplastic drugs in the hospital work environment","volume":"53","author":"Yoshida","year":"2009","journal-title":"Ann Occup Hyg."},{"key":"B20","first-page":"711","article-title":"A test method for assessment of spill and leakage from drug preparation systems","volume":"49","author":"Nygren","year":"2005","journal-title":"Ann Occup Hyg."},{"key":"B21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1177\/001857870303800213","article-title":"Determining sources of workplace contamination with antineoplastic drugs and comparing conventional IV drug preparation with a closed system","volume":"38","author":"Spivey","year":"2003","journal-title":"Hospit Pharm."},{"key":"B22","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1177\/1078155213517127","article-title":"Impact and appreciation of two methods aiming at reducing hazardous drug environmental contamination: the centralization of the priming of IV tubing in the pharmacy and use of a closed-system transfer device","volume":"20","author":"Guillemette","year":"2014","journal-title":"J Oncol Pharm Pract."},{"key":"B23","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1080\/15459624.2016.1165912","article-title":"Surface wipe sampling for antineoplastic (chemotherapy) and other hazardous drug residue in healthcare settings: methodology and recommendations","volume":"13","author":"Connor","year":"2016","journal-title":"J Occup Environ Hyg."}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.827835\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T05:06:19Z","timestamp":1650258379000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2022.827835\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,18]]},"references-count":23,"alternative-id":["10.3389\/fpubh.2022.827835"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2022.827835","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,18]]},"article-number":"827835"}}